Molbio Diagnostics raises ₹281.5 crore from anchor investors ahead of its IPO, with proceeds to fund infrastructure upgrades and new equipment for manufacturing facilities.
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Leave a Comment